Trial Profile
Dose-Exposure Proportionality of a Novel Recombinant Follicle-Stimulating Hormone (rFSH), FE 999049, Derived from a Human Cell Line, with Comparison Between Caucasian and Japanese Women After Subcutaneous Administration.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Follitropin delta (Primary)
- Indications Female infertility
- Focus Pharmacokinetics
- Sponsors Ferring Pharmaceuticals
- 24 Nov 2015 New trial record